From the Journals

Lack of lupus ‘gold standard’ definition hampers estimates of its incidence, prevalence

View on the News

Lupus remains an ‘enigmatic’ disease

Together, the five national lupus registries funded by the Centers for Disease Control and Prevention provide important information about lupus in populations totaling over 6.5 million from four states and three selected Indian Health Service regions, including mixed urban and rural areas. Studies of this magnitude hold great value because case definitions and case ascertainment methodologies have been standardized, and they incorporate capture-recapture analyses to estimate the completeness of case finding.

Dr. Susan Manzi

Dr. Susan Manzi

It should be noted that in all of the studies, when a different definition for lupus was applied, there were significant changes in incidence and prevalence estimates highlighting a lack of precision when there is no gold standard.

Dr. Joan T. Merrill

Dr. Joan T. Merrill

With better clarity around the definition of lupus that covers more of the spectrum without losing specificity for the pathology and a broader and more refined approach to case ascertainment, our understanding of the real burden of disease in the United States will only improve.

Susan Manzi, MD, is with the department of medicine at the Allegheny Health Network, Pittsburgh, and Joan Merrill, MD, is with the department of arthritis and clinical immunology at the Oklahoma Medical Research Foundation, Oklahoma City. These comments are taken from an accompanying editorial (Arthritis Rheumatol. 2017 Sep 11. doi: 10.1002/art.40190). No conflicts of interest were available.


 

FROM ARTHRITIS & RHEUMATOLOGY

Pages

Recommended Reading

SLE linked to subsequent risk of malignant melanoma
MDedge Dermatology
CC-220 shows efficacy, safety concerns in phase II SLE trial
MDedge Dermatology
FDA approves first specific treatment for giant cell arteritis
MDedge Dermatology
Study confirms new mutation, possible therapeutic target in epidermolysis bullosa
MDedge Dermatology
VIDEO: Troponin acts as atherosclerotic biomarker in patients with lupus
MDedge Dermatology
TWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitis
MDedge Dermatology
New classification system for systemic lupus erythematosus moves forward
MDedge Dermatology
Self-injectable belimumab receives FDA approval for systemic lupus erythematosus
MDedge Dermatology
When the painful ‘bumps’ are calciphylaxis, what’s next?
MDedge Dermatology
POLL: Draft classification criteria for SLE stir controversy
MDedge Dermatology

Related Articles